Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01919918 · ClinicalTrials.gov registry record · Phase 1

Muscle Afferent Feedback Effects in Patients With Heart Failure

A Phase 1 study, sponsored by University of Utah.

Completed
Registry status
Phase 1
Development phase
144
Enrollment target

NCT01919918: Completed Phase 1 study, sponsored by University of Utah.

NCT01919918 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 144 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (140% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01919918, a Phase 1 study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
Phase 1
Development phase
144 participants
Enrollment target

Study Summary

The purpose of the study is to find out more about the mechanism by which neural feedback from the working muscle affects the development of central fatigue during exercise. Subjects with chronic heart failure (HF) and healthy subject counterparts will be tested to determine the mechanisms accounting for the premature fatigue characterizing HF patients during physical activity.

Interventions

  • DRUG Muscle Contraction with Metabolite Solution Administration

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2013-09
Est. Completion 2018-01-03
Phase Phase 1
University of Utah

818 total trials

What the finished NCT01919918 record still lists

NCT01919918 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (140% higher).

The record links to 0 conditions, and to 1 intervention - of which Muscle Contraction with Metabolite Solution Administration is the first listed.

NCT01919918 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01919918 about?

NCT01919918 is a clinical study titled "Muscle Afferent Feedback Effects in Patients With Heart Failure". The purpose of the study is to find out more about the mechanism by which neural feedback from the working muscle affects the development of central fatigue during exercise. Subjects with chronic heart failure (HF) and healthy subject counterparts will be tested to determine the mechanisms accountin...

What is the current status of trial NCT01919918?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 144 participants. The study started on 2013-09. Estimated completion is 2018-01-03.

What interventions are being tested in trial NCT01919918?

The interventions under investigation include: Muscle Contraction with Metabolite Solution Administration (DRUG).

Who is sponsoring clinical trial NCT01919918?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01919918's enrollment target sits among peer trials

144 394th of 2000 higher than 1,600 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01919918, the US trial registry maintained by the National Library of Medicine. NCT01919918 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.